Mirum Pharmaceuticals, Inc. (MIRM)

Pharmaceutical Preparations

Latest Price

$93.90

TTM P/E

Normalized P/E

Div Yield

Book Value

4.12

P/B Ratio

22.79

Valuation metrics

Base FCF: $32M (median of recent 5yr)

Growth: 25%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$53.42

43% downside

100.0% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
Frazier Life Sciences Management, L.P.	7.68M	$899.0M	11.86%	--	2026-06-30
Jupiter Topco LLC	5.91M	$691.0M	9.13%	--	2026-06-30
BlackRock, Inc.	4.39M	$513.0M	6.78%	+543.5K	2026-06-30
FMR LLC	3.67M	$429.0M	5.67%	+1.70M	2026-06-30
PRICE T ROWE ASSOCIATES INC /MD/	2.66M	$310.0M	4.10%	+938.2K	2026-06-30
VANGUARD PORTFOLIO MANAGEMENT LLC	2.38M	$278.0M	3.67%	+944.9K	2026-06-30
VANGUARD CAPITAL MANAGEMENT LLC	2.25M	$263.0M	3.48%	-160.7K	2026-06-30
STATE STREET CORP	2.17M	$254.0M	3.35%	+226.4K	2026-06-30
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	1.40M	$164.0M	2.17%	+1.07M	2026-06-30
GEODE CAPITAL MANAGEMENT, LLC	1.39M	$163.0M	2.15%	+133.9K	2026-06-30